Related Experiment Video
Updated: Apr 11, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Combinations of Kinase Inhibitors Protecting Myoblasts against Hypoxia
Yunyi Kang1, Matthew Tierney1, Edison Ong2
1Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America.
Abstract:
Cell-based therapies to treat skeletal muscle disease are limited by the poor survival of donor myoblasts, due in part to acute hypoxic stress. After confirming that the microenvironment of transplanted myoblasts is hypoxic, we screened a kinase inhibitor library in vitro and identified five kinase inhibitors that protected myoblasts from cell death or growth arrest in hypoxic conditions. A systematic, combinatorial study of these compounds further improved myoblast viability, showing both synergistic and additive effects. Pathway and target analysis revealed CDK5, CDK2, CDC2, WEE1, and GSK3β as the main target kinases. In particular, CDK5 was the center of the target kinase network. Using our recently developed statistical method based on elastic net regression we computationally validated the key role of CDK5 in cell protection against hypoxia. This method provided a list of potential kinase targets with a quantitative measure of their optimal amount of relative inhibition. A modified version of the method was also able to predict the effect of combinations using single-drug response data. This work is the first step towards a broadly applicable system-level strategy for the pharmacology of hypoxic damage.
Insights
Kinase inhibitors protect transplanted muscle cells from hypoxic stress, improving survival for skeletal muscle disease therapies. CDK5 plays a key role in this cell protection mechanism.
Area of Science:
- Biomedical Sciences
- Cell Biology
- Pharmacology
Background:
- Cell-based therapies for skeletal muscle disease face challenges due to poor donor myoblast survival.
- Acute hypoxic stress in the transplantation microenvironment is a major contributor to myoblast cell death and growth arrest.
Purpose of the Study:
- To identify kinase inhibitors that enhance myoblast survival under hypoxic conditions.
- To investigate the role of specific kinases, particularly CDK5, in protecting myoblasts against hypoxia.
- To develop and validate computational methods for predicting drug efficacy and combinations.
Main Methods:
- Screening of a kinase inhibitor library to identify compounds protecting myoblasts from hypoxia-induced cell death.
- Combinatorial studies of identified inhibitors to assess synergistic and additive effects on myoblast viability.
- Pathway and target analysis to identify key kinases, including CDK5, CDK2, CDC2, WEE1, and GSK3β.
- Computational validation using elastic net regression to confirm the role of CDK5 and predict optimal inhibition levels.
Main Results:
- Five kinase inhibitors were identified that significantly protected myoblasts from hypoxic stress.
- Combinatorial treatment with these inhibitors further improved myoblast viability, demonstrating synergistic and additive effects.
- CDK5 was identified as a central kinase in the protective network, with CDK2, CDC2, WEE1, and GSK3β also implicated.
- A novel statistical method computationally validated CDK5's role and predicted optimal drug combinations.
Conclusions:
- Kinase inhibitors represent a promising strategy to improve the survival of transplanted myoblasts in hypoxic environments.
- Targeting specific kinases, especially CDK5, can mitigate hypoxic damage and enhance the efficacy of cell-based therapies for skeletal muscle diseases.
- The developed computational methods offer a powerful tool for drug discovery and optimization in the context of hypoxic stress.
More Related Videos
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
07:14A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
Published on: July 13, 2018
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
Inhibition of Cdk Activity
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...